Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

More Moringa recalled due to Salmonella

By Adriana Zimova on July 19, 2026
Email this postTweet this postLike this postShare this post on LinkedIn

Relay Peak Research LLC (Zen Principle Naturals) of Incline Village, NV is voluntarily recalling its Zen Principle® brand Moringa Capsules dietary supplement because the product has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.

The product was distributed nationwide from December 2025 through July 2026, sold to consumers online primarily through Amazon.com and the company’s website, zenprinciple.com. Additionally, one unit was sold on eBay and one unit on Etsy.

The recalled product is Zen Principle® brand Moringa Capsules, 180 capsules packaged in a plastic bottle. The lot number (Lot A6FF4) and Best By date (11/2028) are printed on the bottom of the bottle. The product is offered as a 1-pack (180 capsules; Amazon code/FNSKU X000ZJJ4FT) and as a 2-pack (twin pack, 360 capsules; Amazon code/FNSKU X00159YJXP). No other products are impacted.

No illnesses have been reported to date.

The recall was initiated after the company was notified by its ingredient supplier that FDA testing of the moringa leaf powder used to manufacture the product returned positive for Salmonella. That raw material was used to produce this single lot of finished product. The company has ceased all sale and distribution of the product and is cooperating fully with the U.S. Food and Drug Administration.

Photo of Adriana Zimova Adriana Zimova

Adriana Zimova, JD, MPA, joined Marler Clark as a Litigation Attorney in October 2025.  Adriana earned her JD from Harvard Law School, cum laude, and her MPA in International Development from Harvard Kennedy School.

Following graduation from law school, Adriana joined Cleary…

Adriana Zimova, JD, MPA, joined Marler Clark as a Litigation Attorney in October 2025.  Adriana earned her JD from Harvard Law School, cum laude, and her MPA in International Development from Harvard Kennedy School.

Following graduation from law school, Adriana joined Cleary Gottlieb Steen & Hamilton LLP in Washington, DC, where she represented multi-national corporations in litigation and antitrust matters.  She later worked as a racial justice advocate, authoring a report for the Open Society Justice Initiative titled, Strategic Litigation Impacts: Roma School Desegregation, and co-directing a short advocacy video, Teaching Racism.  Adriana grew passionate about the intersection of food and public health during the time focused on her family.  Prior to joining Marler Clark, Adriana consulted on a potential high-impact public health litigation and co-authored a study on policies that regulate non-sugar sweeteners.

While at law school, Adriana served as a research assistant to Martha Minow, a former Dean of Harvard Law School, and was active on the International Law Journal and with the Harvard Human Rights Program.  She was also the recipient of the Dean’s Scholar Prize in three subjects.

In 2012, Adriana was named one of Forbes 30 under 30 in Law & Policy.

Adriana was born in rural Slovakia.  She now resides on Bainbridge Island, WA, with her husband and two children.

Read more about Adriana ZimovaEmail
Show more Show less
  • Posted in:
    Food, Drug & Agriculture
  • Blog:
    Food Poison Journal
  • Organization:
    Marler Clark, Inc., PS
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo